MedinCell S.A. (MDCLF)
USD 6.98
(-0.06%)
USD 6.98
(-0.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 77.77 Million EUR | 8.57% |
| 2023 | 71.63 Million EUR | 24.2% |
| 2022 | 57.67 Million EUR | 5.46% |
| 2021 | 54.69 Million EUR | 26.41% |
| 2020 | 43.26 Million EUR | 36.31% |
| 2019 | 31.73 Million EUR | -14.45% |
| 2018 | 37.1 Million EUR | 45.2% |
| 2017 | 25.55 Million EUR | 159.47% |
| 2016 | 9.84 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 76.23 Million EUR | 6.43% |
| 2024 Q2 | 76.23 Million EUR | 0.0% |
| 2024 Q3 | 77.77 Million EUR | 2.01% |
| 2024 Q4 | 77.77 Million EUR | 0.0% |
| 2024 FY | 77.77 Million EUR | 8.57% |
| 2023 Q4 | 71.63 Million EUR | 0.0% |
| 2023 Q1 | 58.84 Million EUR | 2.03% |
| 2023 Q2 | 58.84 Million EUR | 0.0% |
| 2023 Q3 | 71.63 Million EUR | 21.73% |
| 2023 FY | 71.63 Million EUR | 24.2% |
| 2022 Q2 | 56.42 Million EUR | 0.0% |
| 2022 FY | 57.67 Million EUR | 5.46% |
| 2022 Q4 | 57.67 Million EUR | 0.0% |
| 2022 Q3 | 57.67 Million EUR | 2.21% |
| 2022 Q1 | 56.42 Million EUR | 3.18% |
| 2021 Q1 | 53.16 Million EUR | 22.87% |
| 2021 FY | 54.69 Million EUR | 26.41% |
| 2021 Q4 | 54.69 Million EUR | 0.39% |
| 2021 Q3 | 54.47 Million EUR | 2.48% |
| 2021 Q2 | 53.16 Million EUR | 0.0% |
| 2020 FY | 43.26 Million EUR | 36.31% |
| 2020 Q4 | 43.26 Million EUR | 0.0% |
| 2020 Q3 | 43.26 Million EUR | 16.09% |
| 2020 Q2 | 37.26 Million EUR | 0.0% |
| 2020 Q1 | 37.26 Million EUR | 17.42% |
| 2019 FY | 31.73 Million EUR | -14.45% |
| 2019 Q4 | 31.73 Million EUR | 0.0% |
| 2019 Q2 | 47.84 Million EUR | 0.0% |
| 2019 Q3 | 31.73 Million EUR | -33.66% |
| 2019 Q1 | 47.84 Million EUR | 28.96% |
| 2018 Q3 | 37.1 Million EUR | 0.0% |
| 2018 Q4 | 37.1 Million EUR | 0.0% |
| 2018 FY | 37.1 Million EUR | 45.2% |
| 2018 Q1 | - EUR | 0.0% |
| 2017 FY | 25.55 Million EUR | 159.47% |
| 2016 FY | 9.84 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 50.26 Million USD | -54.727% |
| Skye Bioscience, Inc. | 14.07 Million USD | -452.663% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -31.786% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -9515.798% |
| Qrons Inc. | 1.48 Million USD | -5124.11% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 15.9 Million USD | -388.989% |
| CSL Limited | 18.62 Billion USD | 99.582% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -7.315% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -721.6% |
| Regen BioPharma, Inc. | 5.45 Million USD | -1325.018% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -3.807% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -173902.148% |
| Rebus Holdings, Inc. | 5.24 Million USD | -1383.632% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -283397.977% |
| Neon Bloom, Inc. | 1.22 Million USD | -6242.454% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -38570.22% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -45.9% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -711.645% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -18348.269% |
| SQZ Biotechnologies Company | 50.03 Million USD | -55.423% |
| Intellipharmaceutics International Inc. | 12 Million USD | -547.627% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -1919.305% |
| Mesoblast Limited | 188.44 Million USD | 58.73% |
| Marizyme, Inc. | 26.67 Million USD | -191.546% |
| Genus plc | 485 Million USD | 83.965% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -1231.115% |
| Pharming Group N.V. | 244.07 Million USD | 68.136% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -3769.003% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -2990.694% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -1946.632% |
| ContraFect Corporation | 32.53 Million USD | -139.07% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -3825.286% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -1931.848% |
| IMV Inc. | 37.93 Million USD | -105.026% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -560.305% |
| MultiCell Technologies, Inc. | 1617.67 USD | -4807555.455% |
| ONE Bio Corp. | 27.49 Million USD | -182.85% |
| Accustem Sciences Inc. | 1.07 Million USD | -7106.189% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -0.459% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -3577.043% |
| Q BioMed Inc. | 8.13 Million USD | -856.259% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 6.225% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -1411.299% |
| Biomind Labs Inc. | 1.49 Million USD | -5089.602% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 34.492% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -760.101% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -322.595% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -5323.957% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -54632.397% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -1253.54% |
| GB Sciences, Inc. | 5.41 Million USD | -1335.555% |
| Alpha Cognition Inc. | 7.16 Million USD | -985.477% |
| HST Global, Inc. | 593.59 Thousand USD | -13001.907% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -6076.337% |
| Halberd Corporation | 728.71 Thousand USD | -10572.427% |
| Enzolytics Inc. | 365.26 Million USD | 78.708% |
| Agentix Corp. | 2.51 Million USD | -2997.801% |
| Resverlogix Corp. | 67.39 Million USD | -15.396% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -9172.569% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 82.521% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -4437.456% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -214.281% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -553.376% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -2021.924% |
| AVAX Technologies, Inc. | 3.99 Million USD | -1847.345% |
| Zenith Capital Corp. | 27.56 Thousand USD | -281999.46% |
| Genscript Biotech Corporation | 1.32 Billion USD | 94.134% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -32487.763% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -1982.636% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -11323.049% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -2768.079% |
| Kadimastem Ltd | 3.5 Million USD | -2118.972% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -116100.75% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -16635.995% |
| LadRx Corporation | 2.2 Million USD | -3434.243% |
| Cell Source, Inc. | 15.8 Million USD | -392.019% |
| Regen BioPharma, Inc. | 5.45 Million USD | -1325.018% |
| NovAccess Global Inc. | 7.86 Million USD | -889.374% |
| Affymax, Inc. | 8.87 Million USD | -776.699% |
| Itoco Inc. | 1.65 Million USD | -4604.47% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -3690.862% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -1185.7% |
| Mobile Lads Corp. | 1.31 Million USD | -5820.988% |
| CytoDyn Inc. | 127.89 Million USD | 39.19% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -185961.868% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -4865.088% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -604.119% |
| SYBLEU INC | 681.41 Thousand USD | -11313.343% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -1174.553% |
| International Stem Cell Corporation | 5.27 Million USD | -1373.792% |
| Bioxytran, Inc. | 3.24 Million USD | -2293.353% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -12327.434% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -1584.425% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -89.706% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -249.302% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -3739.859% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -1319.715% |
| Neutra Corp. | 973.52 Thousand USD | -7888.668% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -168.041% |
| PureTech Health plc | 125.58 Million USD | 38.071% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -1969.987% |
| IXICO plc | 1.9 Million USD | -3992.634% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -278.84% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 24.73% |
| CSL Limited | 18.62 Billion USD | 99.582% |
| Cellectis S.A. | 249.36 Million USD | 68.813% |